Search research articles
Contact Us
Filters
Showing results (591-600 of 3,552) with videos related to
Page
of 356
Sort By:
Bioanalysis
|
July 25, 2017
Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons
Jing Tu, Patrick Bennett
Bioanalysis
|
August 18, 2017
Post-acquisition data mining techniques for LC-MS/MS-acquired data in drug metabolite identification
Pooja Sukhdev Dhurjad, Vamsi Krishna Marothu, Rajeshwari Rathod
Bioanalysis
|
August 2, 2017
Changing shape: evolving an outsourced bioanalytical strategy to support the changing needs of drug development
Craig Stovold, Fiona Milligan, Glen Hawthorne, et al.
Bioanalysis
|
August 2, 2017
Method transfer: a CRO perspective
Martijn J Hilhorst, Barry Wa van der Strate, Chad J Briscoe, et al.
Bioanalysis
|
August 2, 2017
The changing world of bioanalysis: summary of panel discussions
Neil Spooner, Melanie Anderson, Lieve Dillen, et al.
Bioanalysis
|
August 2, 2017
Interactions between clients and outsourced CROs: mind the gap
Richard Hucker, Ian James, Scott Vincent, et al.
Bioanalysis
|
August 2, 2017
Bioanalytical outsourcing models in pharmaceutical companies
Dieter Zimmer
Bioanalysis
|
August 2, 2017
Bioanalytical outsourcing: transitioning from Pharma to CRO
Roger Hayes
Bioanalysis
|
August 3, 2017
Future trends in outsourcing: a summary of the Bioanalysis Zone Survey
Amy Craddock, Sankeetha Nadarajah
Bioanalysis
|
June 16, 2016
Old to new ligand-binding assay method modifications
Bruce Stouffer, Dennis Stocker
Page
of 356
Search research articles
Search
Showing results (591-600 of 3,552) with videos related to
Sort By:
Page
of 356
Bioanalysis
|
July 25, 2017
Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons
Jing Tu, Patrick Bennett
Bioanalysis
|
August 18, 2017
Post-acquisition data mining techniques for LC-MS/MS-acquired data in drug metabolite identification
Pooja Sukhdev Dhurjad, Vamsi Krishna Marothu, Rajeshwari Rathod
Bioanalysis
|
August 2, 2017
Changing shape: evolving an outsourced bioanalytical strategy to support the changing needs of drug development
Craig Stovold, Fiona Milligan, Glen Hawthorne, et al.
Bioanalysis
|
August 2, 2017
Method transfer: a CRO perspective
Martijn J Hilhorst, Barry Wa van der Strate, Chad J Briscoe, et al.
Bioanalysis
|
August 2, 2017
The changing world of bioanalysis: summary of panel discussions
Neil Spooner, Melanie Anderson, Lieve Dillen, et al.
Bioanalysis
|
August 2, 2017
Interactions between clients and outsourced CROs: mind the gap
Richard Hucker, Ian James, Scott Vincent, et al.
Bioanalysis
|
August 2, 2017
Bioanalytical outsourcing models in pharmaceutical companies
Dieter Zimmer
Bioanalysis
|
August 2, 2017
Bioanalytical outsourcing: transitioning from Pharma to CRO
Roger Hayes
Bioanalysis
|
August 3, 2017
Future trends in outsourcing: a summary of the Bioanalysis Zone Survey
Amy Craddock, Sankeetha Nadarajah
Bioanalysis
|
June 16, 2016
Old to new ligand-binding assay method modifications
Bruce Stouffer, Dennis Stocker
Page
of 356